Episurf Medical achieved a milestone with the planning of the 900th surgery with the Episealer® knee implant. Close to 400 patients have had the implant for more than two years, and approximately 70 patients have passed five years since surgery. Studies have shown excellent clinical improvements and a low revision rate.
Preliminary results from a study of Episurf Medical’s Episealer® Knee implant show good patient satisfaction and good knee function after follow-up with 90% of patients. The study is titled “X-ray fluoroscopic analysis of knee joint kinematic in open and closed chain activities in patients with Episealer Knee implants.” The objective of this retrospective study is to measure the knee function of patients who received an Episealer vs. those who received a total knee prosthesis, as well as with patients with healthy, untreated knees.
The device treats focal cartilage and osteochondral defects on the femoral side, and is tailored to fit each patient’s joint surface curvature, size and shape of the lesion and underlying bone conditions.
“We are pleased to have reached this milestone at the end of the year. Despite a very challenging year for elective surgeries, our customers have continued to order Episealer implants when possible. We are looking forward to continued growth, supported by strong clinical evidence,” said Pål Ryfors, CEO.
